1-Methoxy-4-(1-methoxy-1-methylethyl)-1-methylcyclohexane
Common Name: |
1-Methoxy-4-(1-methoxy-1-methylethyl)-1-methylcyclohexane |
IUPAC Name: |
1-methoxy-4-(2-methoxypropan-2-yl)-1-methylcyclohexane |
Molecular Formula: |
C7H14OS |
SMILES: |
CC1(CCC(CC1)C(C)(C)OC)OC |
Inchi: |
1S/C12H24O2/c1-11(2,13-4)10-6-8-12(3,14-5)9-7-10/h10H,6-9H2,1-5H3 |
Inchi Key: |
GGRDCTPZRBUOJU-UHFFFAOYSA-N |
Cas No: |
26946-66-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
146.25 |
Mass (g/mol) |
200.178 |
Molar Refractivity |
43.55 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
42.37 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
219.00 to 220.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.177 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.86 |
LogP |
3.007 |
iLOGP |
1.97 |
XLOGP3 |
1.63 |
WLOGP |
2.11 |
MLOGP |
1.74 |
ESOL Log S |
-1.44 |
ESOL Solubility (mg/ml) |
5.27 |
ESOL Solubility (mol/l) |
0.036 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.13 |
Ali Solubility (mg/ml) |
1.08 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.96 |
Silicos-IT Solubility (mg/ml) |
1.62 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.03 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.648 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.332 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |